alexandria semaglutide & tirzepatide Tirzepatide Surges, Overtakes Older Drugs in Diabetes, Obesity Care Tirzepatide Tops Semaglutide for Weight

Our team views BPC 157 as a more localized agent, excellent for targeting specific connective tissue injuries

Listen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction (00:04:40) - $50 of Dried Lizard Venom (00:29:17) - Fax of Death (00:43:04) - Sleeping Beauty Awakens (00:52:07) - Carl Icahn Sends a Letter (01:09:19) - Endgame (01:13:40) - Postmortem & Playbook CREDITS Co-hosted by Alex Kesin and Matthew Pech Written, edited, and produced by Alex Kesin Music: Food by nerowski * Special thanks to the team at NFX for the use of their recording studio

1 A 2024 systematic review of GLP-1 receptor agonist drug interactions found that while these medications can slightly delay the absorption of some oral drugs due to slower stomach emptying, overall drug exposure remained unaffected

Read the full report to explore the data, strategies and future outlook shaping the GLP-1 landscape

It is also not a treatment for type 1 diabetes

The injectable, which is aimed at adults struggling with excess weight and for adolescents aged 1217 over 60 kilograms (132 lbs), is the first and only generic GLP-1 currently available